IPO Listed

Parabilis Medicines IPO

US$670m raised

Lodged 9 Jun 2026 · NASDAQ: PBLS · US$20.00 per share

Advisers

Parabilis Medicines

Issuer

Legal adviser
Issuer
Parabilis Medicines
Issuer based in
United States
Listed
12 Jun 2026
Sector
Biotech
Tags
Biotech, Drug Development, Oncology

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.